ACM
CELG

Avalon Capital Management’s Celgene Corp CELG Stock Holding History

Avalon Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,970
Closed -$1.19M – 46
2019
Q3 		$1.19M Sell
11,970
-1,100
-8% -$105K 1.41% 20
2019
Q2 		$1.21M Sell
13,070
-3,350
-20% -$318K 1.38% 20
2019
Q1 		$1.55M Buy
+16,420
New +$1.44M 1.31% 21
2018
Q4 		– Sell
-13,595
Closed -$1.22M – 63
2018
Q3 		$1.22M Sell
13,595
-75
-0.5% -$6.63K 1.11% 28
2018
Q2 		$1.09M Buy
+13,670
New +$1.14M 1.08% 26
2017
Q4 		– Sell
-14,931
Closed -$2.18M – 109
2017
Q3 		$2.18M Sell
14,931
-3,342
-18% -$455K 1.51% 20
2017
Q2 		$2.37M Sell
18,273
-134
-0.7% -$16.4K 1.75% 21
2017
Q1 		$2.29M Buy
18,407
+1,668
+10% +$200K 1.59% 20
2016
Q4 		$1.94M Buy
16,739
+8,319
+99% +$926K 1.48% 24
2016
Q3 		$880K Buy
+8,420
New +$911K 0.68% 42

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Avalon Capital Management's CELG Position: Q4 2019 in Review

Avalon Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,970 shares — an estimated $1.19M sold.

Avalon Capital Management first reported a position in CELG in Q3 2016 and held it in 10 quarters. The position peaked at $2.37M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Avalon Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Avalon Capital Management sold 11,970 Celgene Corp shares in Q4 2019, an estimated $1.19M.
  • Avalon Capital Management first reported a position in Celgene Corp in Q3 2016 and held it in 10 quarters.
  • Avalon Capital Management's Celgene Corp position peaked at $2.37M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Avalon Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.